Literature DB >> 16151910

Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa.

S Wendt1, C Whybra, C Kampmann, E Teichmann, M Beck.   

Abstract

Fabry disease is an inherited lysosomal storage disease caused by deficiency of alpha-galactosidase A. Enzyme replacement therapy for this multisystem progressive disease has been available only since 2001. We here report the first known successful pregnancy of a female patient receiving such therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151910     DOI: 10.1007/s10545-005-0018-9

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  3 in total

1.  Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females.

Authors:  K D MacDermot; A Holmes; A H Miners
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

2.  Enzyme replacement therapy in heterozygous females with Fabry disease: results of a phase IIIB study.

Authors:  F Baehner; C Kampmann; C Whybra; E Miebach; C M Wiethoff; M Beck
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

3.  Pregnancies in Gaucher disease: a 5-year study.

Authors:  Yonatan Elstein; Vered Eisenberg; Sorina Granovsky-Grisaru; Ron Rabinowitz; Arnon Samueloff; Ari Zimran; Deborah Elstein
Journal:  Am J Obstet Gynecol       Date:  2004-02       Impact factor: 8.661

  3 in total
  5 in total

1.  Multidisciplinary Team Approach Is Key for Managing Pregnancy and Delivery in Patient with Rare, Complex MPS I.

Authors:  J Troko; Y Poonawala; T Geberhiwot; B Martin
Journal:  JIMD Rep       Date:  2016-02-27

2.  Pregnancy issues in inherited metabolic disorders.

Authors:  Philip J Lee
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

3.  Enzyme replacement therapy in a patient of heterozygous Fabry disease: clinical and pathological evaluations by repeat kidney biopsy and a successful pregnancy.

Authors:  Yoichi Iwafuchi; Hiroki Maruyama; Tetsuo Morioka; Seiko Noda; Hiroshi Nagata; Yuko Oyama; Ichiei Narita
Journal:  CEN Case Rep       Date:  2017-10-10

4.  Prevalence of symptoms in female Fabry disease patients: a case-control survey.

Authors:  Machtelt G Bouwman; Saskia M Rombach; Erica Schenk; Annelies Sweeb; Frits A Wijburg; Carla E M Hollak; Gabor E Linthorst
Journal:  J Inherit Metab Dis       Date:  2012-03-20       Impact factor: 4.982

Review 5.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.